ask="6.15"
ask_size="500"
average_daily_volume="958376"
bid="5.99"
bid_size="2000"
book_value="0.05"
change="+0.09"
change_from_200_day_moving_average="1.29"
change_from_50_day_moving_average="-0.09"
change_from_52_week_high="-1.91"
change_From_52_week_low="4.41"
change_in_percent="+1.51%"
close="6.04"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.94"
ebitda="-57.26M"
eps_estimate_current_year="-0.91"
eps_estimate_next_quarter="-0.22"
eps_estimate_next_year="-0.83"
ex_dividend_date="N/A"
float_shares="42598000"
high="6.14"
high_52_weeks="7.95"
last_trade_date="1/19/2017"
last_trade_price="6.04"
last_trade_size="23743"
last_trade_time="4:00pm"
low="5.95"
low_52_weeks="1.63"
market_capitalization="445.50M"
moving_average_200_day="4.75"
moving_average_50_day="6.13"
name="BioCryst Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="7.08"
open="5.95"
pe_ratio="N/A"
peg_ratio="-0.35"
percent_change_from_200_day_moving_average="+27.17%"
percent_change_from_50_day_moving_average="-1.53%"
percent_change_from_52_week_high="-24.05%"
percent_change_from_52_week_low="+270.55%"
previous_close="5.95"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="110.19"
price_per_sales="19.97"
revenue="21.97M"
shares_outstanding="73758000"
short_ratio="8.02"
stock_exchange="NMS"
symbol="BCRX"
volume="708794"
weeks_range_52="1.63 - 7.95"
